Welcome to LookChem.com Sign In|Join Free

CAS

  • or
TOBRAMYCIN A is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

236401-43-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 236401-43-7 Structure
  • Basic information

    1. Product Name: TOBRAMYCIN A
    2. Synonyms: D-Streptamine, 4-O-(3-amino-3-deoxy-α-D-glucopyranosyl)-2-deoxy- (9CI)
    3. CAS NO:236401-43-7
    4. Molecular Formula: C12H25 N3 O7
    5. Molecular Weight: 323.34
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 236401-43-7.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: TOBRAMYCIN A(CAS DataBase Reference)
    10. NIST Chemistry Reference: TOBRAMYCIN A(236401-43-7)
    11. EPA Substance Registry System: TOBRAMYCIN A(236401-43-7)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 236401-43-7(Hazardous Substances Data)

236401-43-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 236401-43-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,3,6,4,0 and 1 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 236401-43:
(8*2)+(7*3)+(6*6)+(5*4)+(4*0)+(3*1)+(2*4)+(1*3)=107
107 % 10 = 7
So 236401-43-7 is a valid CAS Registry Number.

236401-43-7Downstream Products

236401-43-7Relevant articles and documents

Synthesis of ring II/III fragment of Kanamycin: A new minimum structural motif for aminoglycoside recognition

Zárate, Sandra G.,Bastida, Agatha,Santana, Andrés G.,Revuelta, Julia

, (2019/08/20)

A novel protocol has been established to prepare the kanamycin ring II/III fragment, which has been validated as a minimum structural motif for the development of new aminoglycosides on the basis of its bactericidal activity even against resistant strains. Furthermore, its ability to act as a AAC-(6′) and APH-(3′) binder, and as a poor substrate for the ravenous ANT-(4′), makes it an excellent candidate for the design of inhibitors of these aminoglycoside modifying enzymes.

Design and synthesis of new aminoglycoside antibiotics containing neamine as an optimal core structure: Correlation of antibiotic activity with in vitro inhibition of translation

Greenberg, William A.,Priestley, E. Scott,Sears, Pamela S.,Alper, Phil B.,Rosenbohm, Christoph,Hendrix, Martin,Hung, Shang-Cheng,Wong, Chi-Huey

, p. 6527 - 6541 (2007/10/03)

The structure and activity of the pseudodisaccharide core found in aminoglycoside antibiotics was probed with a series of synthetic analogues in which the position of amino groups was varied around the glucopyranose ring. The naturally occurring structure

Synthesis of kanamycin A analogs containing 6-amino-3-oxa-2,3,4,6-tetradeoxy-D- and -L-glycero-hexopyranose

Kuwahara, Ryuji,Tsuchiya, Tsutomu

, p. 107 - 122 (2007/10/03)

6-Azido-3-oxa-2,3,4,6-tetradeoxy-D- and -L-glycero-hexopyranoses were synthesized in five steps from (2S)- and (2R)-1,2-O-isopropylideneglycerols, respectively. After conversion into the corresponding ethyl 1-thioglycosides, each was condensed with a protected derivative of 6-O-(3-amino-3-deoxy-α-D-glucopyranosyl)-2-deoxystreptamine (16). Deprotection and reduction of the azido group of the condensation products gave the title compounds.

Synthesis of 4'-deoxy-4'-fluorokanamycin A and B

Takahashi, Yoshiaki,Tsuneda, Sayori,Tsuchiya, Tsutomu,Koyama, Yoshiko,Umezawa, Sumio

, p. 89 - 106 (2007/10/02)

4'-Deoxy-4'-fluorokanamycins A (17) and B (25) have been prepared through fluorinating ring-opening of the D-galacto-3',4'-oxiranes (8 and 21) derived from kanamycin A and B with potassium hydrogenfluoride in ethane-1,2-diol.The mechanism of preponderant formation of the 4'-deoxy-4'-fluoro-D-gluco ( 9 and 22) over the 3'-deoxy-3'-fluoro-D-gulo derivatives was discussed.In the synthesis of 25, the unusual 3',6'-epimine (23) was the main product along with the 4'-deoxy-4'-fluoro derivative.The mechanism of this reaction is also discussed.Both 17 and 25 were active against resistant bacteria producing aminoglycoside-adenylylating enzymes for HO-4'.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 236401-43-7